How your contribution can make a difference

Would you like to be part of oncology - medical research in Australia?

 

Over 100,000 Australians are newly diagnosed with cancer every year. For more than 10 years, Ipsos has conducted ongoing market research to understand the dynamics around current and future cancer therapies by physicians, and this research is used to improve anti-cancer drugs by some of the largest pharmaceutical companies in the world.

Your contributions are important in shaping the oncology market in Australia

  • Our research compares cancer treatment paradigms nationally and across different states/territories of Australia.
  • We uncover whether patients receive treatment via compassionate Access Programs, and which drugs are covered in those programs.
  • Patient segmentation data is used to identify unmet needs.
  • Clinical trial use is quantified and treatments being prescribed through clinical trials are uncovered.
  • Be rewarded for your contribution and be paid for each survey completed. Earn up to $2000 per quarter
  • Participation is flexible and voluntary – submit patient charts online each month, or less frequent as your schedule allows

  • In accordance with Privacy Laws, your participation will remain confidential and your individual responses anonymous. Your responses will be aggregated and reported along with others' responses. 

About our study

  • Ipsos have been running the Oncology Patient Audit Study for more than a decade in Australia, which is syndicated to around 30 markets worldwide.
  • We have also successfully published the information collected at local and global conferences and abstracts (including COSA and ASCO).

Ready to make a difference? Join our panel today!

Sign up HERE!

Once signed up, our friendly Ipsos staff will contact you for further details on the study, and send you a personalised link to start contributing.

Ipsos is an ISO certified company and adhere to ISO standards. Ipsos operates in full compliance with EphMRA, AMSRS and ESOMAR guidelines.

For more info, please contact: [email protected]

If you’re interested to join our panel, please click here.

Do you have a colleague who would be interested in joining our panel? Click to forward this to a friend